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artery and peripheral artery atherosclerosis have not been well
described.
METHODS CLARITY was a prospective, multi-center trial in which 50
peripheral arterial disease (PAD) pts with a lower extremity wound fed
by a diseased tibial or peroneal artery with diameter stenosis >50%
were enrolled to evaluate orbital atherectomy compared to balloon
angioplasty alone using intravascular ultrasound (IVUS). ADAPT-DES
was a prospective, multicenter, “all-comers” registry of 8582 coronary
artery disease (CAD) pts undergoing successful percutaneous coro-
nary intervention (PCI); a pre-speciﬁed substudy included 780 pts
with baseline IVUS data. We compared pre-intervention IVUS ﬁndings
in 42 PAD lesions from CLARITY vs 79 CAD lesions from ADAPT that
were matched 1:2 for age, gender, diabetes, hypertension, hyperlip-
idemia, and renal insufﬁciency. Vessel and lumen were measured
every 1 mm, and total volume and mean volume (¼volume/length)
were calculated. Furthermore, within each lesion 5 equidistantly
spaced cross-sections from the proximal to the distal edge were
identiﬁed, and calcium arc and plaque eccentricity (min/max plaque
thickness) were analyzed.
RESULTS Compared to CAD lesions, PAD lesions had 1) smaller mean
vessel, plaque and lumen volumes; and 2) twice the lesion length
(Table). Maximum superﬁcial calcium arc and plaque eccentricity
measures at the MLA were greater (ie. more concentric plaque) in
PAD lesions than in CAD lesions. Calcium arc and plaque
eccentricity were positively correlated to the plaque burden (PB) in
both PAD and CAD lesions (Figure). Calcium arc and concentricity
were greater in PAD compared to CAD independent of the degree of
plaque burden (PB) (Table).PAD
(n[42)CAD
(n[79) P-valueMinimum lumen area
(mm2)2.0 [1.8, 2.5] 2.5 [2.1, 3.3] <0.001Mean vessel volume
(mm3/mm)8.9 [7.5, 11.4] 12.9 [10.3, 16.3] <0.001Mean lumen volume
(mm3/mm)3.0 [2.5, 3.9] 5.1 [4.3, 6.2] <0.001Mean plaque volume
(mm3/mm)6.0 [4.8, 7.2] 7.0 [5.6, 10.2] 0.008Lesion length (mm) 48.8 [31.5, 87.3] 24.7 [16.1, 42.0] <0.001Maximum superﬁcial
calcium arc ()285 [94, 360] 81 [49, 142] <0.001Calcium arc with
PB <40%0 [0, 44] 0 [0, 0] 0.30Calcium arc with
PB 40%
- <70%77 [10, 164] 45 [0, 90] 0.001Calcium arc with
PB 70%
125 [40, 217] 60 [14, 150] 0.001Concentric plaque
(eccentricity
>0.5)15 (35.7%) 14 (17.7%) <0.001Plaque eccentricity at
the MLA0.41 [0.22, 0.51] 0.22 [0.12, 0.40] 0.002Plaque eccentricity
with PB <40%0.20 [0.13, 0.41] 0.14 [0.07, 0.26] 0.08Plaque eccentricity
with PB 40%
- <70%0.33 [0.20, 0.49] 0.16 [0.07, 0.32] <0.001Plaque eccentricity
with PB 70%
0.37 [0.24, 0.53] 0.27 [0.12, 0.45] 0.03CONCLUSIONS Compared to CAD lesions, PAD lesions were longer,
had more concentric, diffuse, and calciﬁed plaque, and vessels vol-
umes were smaller. These differences may in part explain different
responses to pharmacologic, interventional and surgical therapies.
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BACKGROUND Serial evolution in untreated coronary lesion
morphology associated with and without cardiac events has not pre-
viously been prospectively described.
METHODS In PROSPECT, 3-vessel grayscale and virtual histology
intravascular ultrasound (VH)-IVUS was performed in 697 acute cor-
onary syndrome pts following successful PCI. By protocol, repeat 3-
vessel VH-IVUS was to be performed at the time of major adverse
cardiac events (MACE).
RESULTS During a median follow-up (FU) of 3.4 years, serial VH-
IVUS studies were performed in 44 pts in 144 previously untreated
non-culprit lesions (NCLs); 17 NCLs were responsible for MACE
(Event-NCLs) while 127 NCLs in the same pts were not associated
with events (Non-event-NCL), but were also imaged at follow-up
(control lesions). Baseline minimum lumen area (MLA) was signiﬁ-
cantly smaller [4.0 (3.3, 5.4) mm2 vs 5.9 (4.5, 8.1) mm2, p<0.001]
and plaque burden at the MLA site was greater [71.7 (67.3, 75.0) %
vs 56.9 (50.4, 62.6) %, p<0.001] in Event-NCLs compared to Non-
event-NCLs, although the baseline prevalence of VH-TCFAs was not
different (35.3% vs. 22.0%, p¼0.23) in this subset of pts. Although
the change in plaque volume from baseline to FU was not statisti-
cally different between Event-NCLs and Non-event-NCLs [14.0
(-12.5, 31.4) mm3 vs -4.7 (-26.2, 19.8) mm3, p¼0.24], the increase of
necrotic core [2.9 (-1.3, 12.4) mm3 vs 0.3 (-2.1, 4.9) mm3, p¼0.09]
and dense calcium volume [2.4 (0.6, 7.0) mm3 vs 0.4 (-0.5,
B150 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 52.7) mm3, p¼0.01] tended to be greater in Event-NCLs. The VH-
IVUS phenotype changed from BL to FU in approximately half
of Event-NCLs and Non-event-NCLs, although the overall preva-
lence of each phenotype did not change (Table). New TCFAs from
non-TCFA phenotype developed in 25/110 NCLs (22.7%), including
4/11 Event-NCLs and 21/99 Non-event-NCLs (36.4% vs. 21.2%,
p¼0.26).Event-NCLs Follow-upBaseline TCFA ThCFA PIT Fibrotic Fibro-calciﬁcTCFA 6 (35.3%) 2 4 0 0 0ThCFA 9 (52.9%) 4 5 0 0 0PIT 1 (5.9%) 0 0 1 0 0Fibrotic 0 (0%) 0 0 0 0 0Fibrocalciﬁc 1 (5.9%) 0 1 0 0 0Total 17 6 (35.3%) 10 (58.8%) 1 (5.9%) 0 (0%) 0 (0%)Non-event-NCLsTCFA 28 (22.0%) 12 14 2 0 0ThCFA 46 (36.2%) 9 29 8 0 0PIT 50 (39.4%) 10 13 27 0 0Fibrotic 1 (0.8%) 1 0 0 0 0Fibrocalciﬁc 2 (1.6%) 1 1 0 0 0Total 127 33 (26.0%) 57 (44.9%) 37 (29.1%) 0 (0%) 0 (0%)CONCLUSIONS In the PROSPECT study, new TCFAs developed in
w23% of untreated NCLs during median 3.4 year FU. NCLs causing
events during FU tended to have greater progression of necrotic core
and dense calcium compared to NCLs which did not cause events. A
greater increase in plaque volume was also noted in Event-NCLs
compared to Non-event-NCLs, although the difference did not reach
statistical signiﬁcance.
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BACKGROUND Coronary calciﬁcation is a common ﬁnding in non-
invasive and invasive imaging studies. Coronary computed tomogra-
phy (CT) coronary artery calcium (CAC) testing is the most widely
used and validated score for studying coronary calciﬁcation. It is
considered to be a strong independent predictor of future adverse
cardiovascular events and also gives additional information than the
traditional cardiovascular risk factors. We investigated the natural
history of the coronary calciﬁcation as assessed by OCT in a popula-
tion with serial imaging over a period of 5 years.
METHODS We screened all patients from ABSORB cohort B trial and
we selected only the patients with available OCT data within 6 months
(baseline) after scaffold implantation and at follow-up (5 years). In the
ABSORB B trial (n¼101) patients with a diagnosis of stable or unstable
angina or silent ischemia were enrolled and treated with implantation
of ABSORB (3.0 x 18 mm). OCT datasets (baseline and 5 year follow-
up) were screened for the presence of calcium spots fully visible in
their entire extent without the presence of any artifact that may
prevent proper contouring of the calcium area.
RESULTS A total of 17 patients had 31 matched lesions with calciﬁed
spots at baseline and 5 year follow-up (21 were located outside of the
scaffolded segments and 10 in the scaffolded segments). At baseline,
the median calcium area (IQR) was 0.44 (0.28-0.72) vs. 0.75 (0.61-
0.90) mm2 at 5 years; the mean difference was 0.380.50 mm2,
p<0.001 (representing an 11096.3% increase). The rate of progres-
sion seems to be slower in those calcium spots within the scaffolded
segments compared to those located outside the scaffolded segments.
The mean minimum, maximum and mean distances from the lumen
remain unchanged over time. On average, the circumferential arc of
the calcium reduced slightly (although statistically signiﬁcant) from49.18 to 45.98 degrees while the length of the calcium increased not
signiﬁcantly (table 1).
CONCLUSIONS Near-microscopic resolution intravascular imaging
modality, such as OCT, allows a very detailed and highly reproducible
analysis of the calcium spots. This provides a unique opportunity to
study the natural history of coronary calcium. In a period of 5 years,
the measured calcium spots doubled their size.Baseline 5 years Mean diff PMedian calcium
areas
(IQR), mm20.44 (0.28-0.72) 0.75 (0.61-0.90) 0.380.50 <0.001*Median Min. Dist.
From Lumen
(IQR), mm0.17 (0.06-0.25) 0.20 (0.06-0.25) 0.000.15 0.631*Median Max.
Dist. From
Lumen
(IQR), mm0.31 (0.22-0.51) 0.34 (0.21-0.47) 0.020.16 0.389*Mean Dist. From
Lumen, mm0.260.15 0.260.14 0.000.15 0.890ǂAngle, degrees 49.18 (28.35-
62.56)45.98 (37.07-
88.27)12.3724.03 0.003*Length, mm 1.16 (0.85-1.60) 1.23 (0.95-1.76) 0.120.52 0.126*CATEGORIES IMAGING: Intravascular
KEYWORDS Atherosclerosis, coronary, Calciﬁcation, OCTTCT-369
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BACKGROUND Patients and plaque’s characteristics have been scru-
tinized to understand how risk factors relate to the hazard of subse-
quent cardiovascular events. However, the clinical and health
outcomes measures assessed by the Seattle Angina Questionnaire
(SAQ) have never been correlated with the characteristics of obstruc-
tive plaque determined by intravascular ultrasound (IVUS). The aim of
the present study is to describe the pre-treatment intravascular ul-
trasound (IVUS grey scale and backscatter tissue data) ﬁndings of
obstructive lesions according to patient demographics and health
outcome measures in the ABSORB II trial (ClinicalTrials.gov, number
NCT0142528).
METHODS An independent corelab (Cardialysis, Rotterdam, The
Netherlands) analyzed IVUS segments ﬂanked by the presence of side
branches beyond 5mm distally and 5mm proximally to the to be
treated regions. Patient demographics, anthropometric measures,
cardiovascular risk factors and baseline SAQ were correlated with
IVUS ﬁndings. A multivariate analysis was run to identify variables
related to plaque burden and the largest necrotic core area in these
obstructive lesions.
RESULTS 464 patients had pre-procedural IVUS grey-scale and 438
patients had IVUS radiofrequency assessment before device implan-
tation. The mean age was 61.510.0 years old, 23.3% were female and
25.0% were diabetics. Clinical characteristics were able to differen-
tiate plaque features by IVUS and VH IVUS. Patients with abdominal
obesity (P<0.01) and increase in body mass had more negative
remodeling (P¼0.01), a ﬁnding that was related to worse angina fre-
quency scores by SAQ (P<0.01). Reduction in HDL-C (P¼0.01), lesion
in RCA (P<0.01), lesion in proximal LAD (P<0.01) and worse angina
stability by SAQ (P¼0.03) were independently correlated with plaque
burden. Smaller lumen area (P<0.01), larger vessel area (P<0.01) and
more physical limitation by SAQ (P¼0.03) were independently corre-
lated with the maximum necrotic core area.
